Y-27632 Dihydrochloride: Selective ROCK1/2 Inhibitor for Cytoskeletal and Stem Cell Research

Executive Summary: Y-27632 dihydrochloride is a highly selective, cell-permeable inhibitor of ROCK1 and ROCK2 with IC₅₀ values of 140 nM and 300 nM, respectively, and over 200-fold selectivity against other kinases (APExBIO). It disrupts Rho-mediated stress fiber formation and modulates cell cycle progression from G1 to S phase. The compound enhances stem cell viability and suppresses tumor invasion in vivo and in vitro (Yu et al., 2023). Y-27632 dihydrochloride is soluble at ≥52.9 mg/mL in water and stable in stock solutions below -20°C. Its application is pivotal in studies of cytoskeletal organization, cell proliferation, and cancer invasion (Mouse-IL, 2023).

Biological Rationale

Y-27632 dihydrochloride is a small-molecule inhibitor that targets Rho-associated protein kinases (ROCK1 and ROCK2). These kinases are crucial regulators of actin cytoskeleton dynamics, cell migration, and contractility. The Rho/ROCK signaling pathway controls formation of actin stress fibers, cell adhesion, and cytokinesis (Yu et al., 2023). Inhibition of ROCK kinases leads to decreased cell contractility and altered cell shape, making this pathway a key target for studies in cancer biology, stem cell maintenance, and tissue regeneration. Y-27632's high selectivity for ROCK1/2 allows researchers to dissect Rho/ROCK-dependent processes specifically, minimizing off-target effects on related kinases such as PKC, MLCK, or PAK (APExBIO).

Mechanism of Action of Y-27632 dihydrochloride

Y-27632 dihydrochloride acts by competitively inhibiting the ATP-binding site within the catalytic domains of ROCK1 and ROCK2. The compound exhibits an IC₅₀ of approximately 140 nM for ROCK1 and a K_i of 300 nM for ROCK2 in biochemical assays (APExBIO). By blocking ROCK kinase activity, Y-27632 suppresses phosphorylation of downstream effectors such as myosin light chain (MLC), LIM kinase, and cofilin. This results in disruption of actin stress fiber assembly, inhibition of cell contraction, and decreased focal adhesion formation. In stem cell systems, ROCK inhibition prevents dissociation-induced apoptosis and enhances post-thaw viability (Amadacycline, 2023). In cancer models, Y-27632 impairs migratory and invasive properties by altering cytoskeletal architecture.

Evidence & Benchmarks

• Y-27632 dihydrochloride inhibits ROCK1 with an IC₅₀ of 140 nM and ROCK2 with a K_i of 300 nM, showing over 200-fold selectivity against PKC, cAMP-dependent protein kinase, MLCK, and PAK (APExBIO).
• In vitro, Y-27632 reduces proliferation of prostatic smooth muscle cells in a concentration-dependent manner (APExBIO product documentation, link).
• In vivo administration in mouse tumor models reduces pathological structures and suppresses tumor invasion and metastasis (Yu et al., 2023).
• Y-27632 is effective in maintaining viability and pluripotency of human and mouse intermediate FTW-PSCs in vitro, facilitating efficient primordial germ cell-like cell (PGC-LC) induction (Yu et al., 2023).
• Solubility benchmarks: ≥111.2 mg/mL in DMSO, ≥17.57 mg/mL in ethanol, and ≥52.9 mg/mL in water at 25°C (APExBIO).

For a comprehensive review of Y-27632’s cytoskeletal modulation and translational research applications, see this article (which details strategic applications, whereas the present article focuses on mechanistic and workflow precision). For stem cell viability and neural integration, see this advanced guide (contrasted here by providing primary evidence tables and solubility metrics).

Applications, Limits & Misconceptions

Y-27632 dihydrochloride is employed across multiple research domains:

• Stem cell biology: Enhances survival of dissociated pluripotent stem cells, supports expansion and maintenance of FTW-PSCs, and enables efficient primordial germ cell induction (Yu et al., 2023).
• Cancer research: Reduces tumor cell invasion and metastasis in vivo; impairs cytoskeletal reorganization driving malignancy (APExBIO).
• Cytoskeletal studies: Facilitates analysis of Rho/ROCK-dependent stress fiber formation, cell contraction, and cytokinesis.
• Organoid and tissue engineering: Used to stabilize cell populations during passaging and dissociation (Amadacycline, 2023).

Common Pitfalls or Misconceptions

• Y-27632 is not a pan-kinase inhibitor; it is highly selective for ROCK1/2 and shows minimal activity against PKC, MLCK, and PAK at experimental concentrations (APExBIO).
• It does not fully block all Rho-mediated processes, especially those independent of ROCK kinases.
• Prolonged storage of Y-27632 solutions, especially above -20°C, leads to degradation and loss of potency.
• Repeated freeze-thaw cycles of stock solutions may reduce inhibitor efficacy.
• Not suitable for direct in vivo therapeutic use; intended for research applications only.

Workflow Integration & Parameters

Y-27632 dihydrochloride (SKU: A3008) is supplied as a solid by APExBIO and should be stored desiccated at 4°C or below. For experimental use, dissolve in DMSO (≥111.2 mg/mL), ethanol (≥17.57 mg/mL), or water (≥52.9 mg/mL); solubility can be improved by warming to 37°C or using an ultrasonic bath. Prepare stock solutions fresh when possible; store below -20°C for up to several months, avoiding multiple freeze-thaw cycles. Typical working concentrations in cell culture range from 1–20 μM. When added to stem cell cultures, Y-27632 promotes survival post-dissociation and enhances expansion during passaging. In cancer cell assays, use concentration-response curves to identify cytostatic or cytotoxic effects. Always confirm activity with appropriate controls and monitor for off-target effects at higher concentrations (Yu et al., 2023).

Conclusion & Outlook

Y-27632 dihydrochloride has become a foundational tool for dissecting Rho/ROCK signaling, optimizing stem cell culture, and studying cancer cell invasion. Its high selectivity, established benchmarks, and robust workflow integration have made it indispensable in both basic and translational research. As new stem cell states and regenerative models emerge, precise ROCK inhibition will continue to provide mechanistic clarity and experimental reproducibility (Yu et al., 2023). For ordering and full specifications, visit the Y-27632 dihydrochloride product page from APExBIO.